Experion Holdings Ltd. (V:EXP)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Sector: Healthcare	Industry: Pharmaceuticals

See Regulatory Filings on SEDAR

Company Contact

Address:	12556 Stave Lake Road MISSION BC V2V 0A6
Tel:	N/A
Website:	N/A
IR:	N/A

Key People

Jarrett Malnarick Interim Chairman of the Board, Chief Executive Officer, Chief Operating Officer	Jay Garnett President	Kamini Hitkari Chief Financial Officer

Business Overview

Experion Holdings Ltd., formerly Viridium Pacific Group Ltd, is a Canada-based company that is engaged in the medical cannabis sector. Viridium Pacific Group Ltd owns a controlling interest in Experion Biotechnologies Inc (Experion). Experion Biotechnologies Inc is a science-led company that conducts business in the cannabis production industry. Experion Biotechnologies Inc holds a license to produce cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR), granted by Health Canada. Experion Biotechnologies Inc's objective is the: production of whole plant, starter material; production of dried marijuana flowers, as well as the distribution of its production, including the wholesale distribution of its starter material to licensed growers and marijuana flower product for wholesale and retail distribution across Canada.

Financial Overview

For the six months ended 31 May 2020, Experion Holdings Ltd revenues increased from C$724K to C$2.1M. Net loss decreased 68% to C$1.5M. Revenues reflect Cannabis sales increase from C$762K to C$2.5M. Lower net loss reflects Professional fees decrease of 81% to C$374K (expense), FV Adjustments on Biological Assets decrease from C$71K (expense) to C$528K (income), General and administration decrease of 48% to C$405K (expense).

Reporting Currency:	Canadian Dollars
Enterprise value:	$6.60M as of May 31, 2020
Annual revenue (TTM):	$2.81M as of May 31, 2020
EBITDA (TTM):	-$2.57M as of May 31, 2020
Net annual income (TTM):	-$12.97M as of May 31, 2020
Free cash flow (TTM):	-$6.80M as of May 31, 2020
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	100,612,323 as of Jul 30, 2020
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Disclaimer :: Use of this site is subject to, and your continued use constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information. INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion; however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment. Users should always consult with and obtain advice from their professional licensed financial advisor, including their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment or trading securities do so with caution. Users should perform full due diligence and investigate any security fully before making an investment or before the execution of a security trade based upon information learned through INK. Investors should obtain annual reports and other company information to complete their own due diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this website. On this site, there may be third party content, content from authors or links to third-party sites or pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI® is a registered trade-mark owned by the Alberta Securities Commission.Read less

Company fundamental and price data sourced from © Thomson Reuters Limited. All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. Thomson Reuters is not liable for any errors or delays in Thomson Reuters content, or for any actions taken in reliance on such content. 'Thomson Reuters' and the Thomson Reuters logo are trademarks of Thomson Reuters and its affiliated companies.
US Quotes data provided by IEX.

Interactive technical study charts by TradingView. Copyright © 2020 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.